Older Adults Struggle to Get Pfizer’s $225,000-a-Year Heart Drug

Bookmark
(Bloomberg) -- Pfizer Inc.’s new $225,000-a-year heart drug is being labeled by researchers critical of the cost as “the most expensive cardiac medication in history.”
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.